Submit Deal

Announced

28 Jul 2025

Nordic Capital and Permira withdrew their offer to acquire Bavarian Nordic for DKK19bn.

Synopsis

Nordic Capital and Permira, two private equity firms, withdrew their offer to acquire Bavarian Nordic, a biotechnology company that develops and manufactures vaccines, for DKK19bn.

Principals

target

Bavarian Nordic

bidder

Nordic Capital

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Seller Team (12)

torben hansen

Director at Nordea Bank

Financial Advisor

target

Deals

£ 21.67 B

Total Value

anders knutson

Managing Director at Nordea Bank

Financial Advisor

target

Deals

£ 2.72 B

Total Value

kasper b. dichow

Head of Corporate Finance at Nordea Bank

Financial Advisor

target

Deals

£ 27.93 B

Total Value

niclas herstal

Director at Nordea Bank

Financial Advisor

target

Deals

£ 12.48 B

Total Value

kasper tengel hessellund

‎Associate Director at Nordea Bank

Financial Advisor

target

Deals

£ 12.26 B

Total Value

marcus jensen

Associate at Nordea Bank

Financial Advisor

target

Deals

£ 2.22 B

Total Value

giano grillo

Analyst at Nordea Bank

Financial Advisor

target

Deal

£ 2.22 B

Total Value

jeff hendrickson

Partner at A&O Shearman

Lawyer

target

Deals

£ 19.94 B

Total Value

brandon abrams

Associate at A&O Shearman

Lawyer

target

Deals

£ 6.71 B

Total Value

derrick lott

Partner at A&O Shearman

Lawyer

target

Deals

£ 104.08 B

Total Value

rose whitlock

Associate at A&O Shearman

Lawyer

target

Deal

£ 2.22 B

Total Value

nicholas putz

Associate at A&O Shearman

Lawyer

target

Deals

£ 32.06 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy